Icu Medical Stock Performance
| ICUI Stock | USD 112.44 1.78 1.61% |
On a scale of 0 to 100, ICU Medical holds a performance score of 8. The firm retains a Market Volatility (i.e., Beta) of 1.12, which attests to a somewhat significant risk relative to the market. ICU Medical returns are very sensitive to returns on the market. As the market goes up or down, ICU Medical is expected to follow. Please check ICU Medical's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether ICU Medical's current trending patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in ICU Medical are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, ICU Medical demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.61 | Five Day Return 4.09 | Year To Date Return 10.69 | Ten Year Return 87.46 | All Time Return 2.3 K |
Last Split Factor 3:2 | Last Split Date 2002-03-18 |
1 | Disposition of 463 shares by Sousa Ben of ICU Medical at 98.08 subject to Rule 16b-3 | 03/18/2024 |
2 | Acquisition by Brian Bonnell of 2145 shares of ICU Medical subject to Rule 16b-3 | 03/20/2024 |
3 | Disposition of 791 shares by Woolson Daniel of ICU Medical at 98.2715 subject to Rule 16b-3 | 03/27/2024 |
4 | Sequoia Financial Advisors LLC Acquires Shares of 4975 ICU Medical, Inc. - Defense World | 04/17/2024 |
5 | 05/06/2024 |
6 | ICU Medical Inc. Reports Mixed Q1 2024 Results, Adjusted EPS Beats Estimates | 05/07/2024 |
7 | ICUI Stock Earnings ICU Medical Beats EPS, Beats Revenue for Q1 2024 | 05/08/2024 |
8 | Disposition of 2000 shares by Sousa Ben of ICU Medical at 105.545 subject to Rule 16b-3 | 05/10/2024 |
9 | Disposition of 948 shares by Hernandez Laurie of ICU Medical subject to Rule 16b-3 | 05/15/2024 |
10 | Icu Medical director Elisha Finney sells 31,484 in stock | 05/16/2024 |
11 | Insider Sale Christian Voigtlander Sells 12,5 Shares of ICU Medical Inc | 05/31/2024 |
12 | ICU Medical Stock Jumps 5.8 percent Will It Continue to Soar - Yahoo Canada Shine On | 06/04/2024 |
13 | Campbell CO Investment Adviser LLC Cuts Stock Position in ICU Medical, Inc. - MarketBeat | 06/11/2024 |
| Begin Period Cash Flow | 208.8 M |
ICU |
ICU Medical Relative Risk vs. Return Landscape
If you would invest 9,867 in ICU Medical on March 14, 2024 and sell it today you would earn a total of 1,377 from holding ICU Medical or generate 13.96% return on investment over 90 days. ICU Medical is currently generating 0.2319% in daily expected returns and assumes 2.0682% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than ICU, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ICU Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ICU Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ICU Medical, and traders can use it to determine the average amount a ICU Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1121
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ICUI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.07 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average ICU Medical is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ICU Medical by adding it to a well-diversified portfolio.
ICU Medical Fundamentals Growth
ICU Stock prices reflect investors' perceptions of the future prospects and financial health of ICU Medical, and ICU Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ICU Stock performance.
| Return On Equity | -0.0285 | ||||
| Return On Asset | 0.0048 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 4.11 B | ||||
| Shares Outstanding | 24.37 M | ||||
| Price To Earning | 38.71 X | ||||
| Price To Book | 1.13 X | ||||
| Price To Sales | 1.06 X | ||||
| Revenue | 2.26 B | ||||
| Gross Profit | 697.76 M | ||||
| EBITDA | 290.37 M | ||||
| Net Income | (29.66 M) | ||||
| Cash And Equivalents | 285.59 M | ||||
| Cash Per Share | 11.95 X | ||||
| Total Debt | 1.7 B | ||||
| Debt To Equity | 0.84 % | ||||
| Current Ratio | 2.45 X | ||||
| Book Value Per Share | 84.87 X | ||||
| Cash Flow From Operations | 166.2 M | ||||
| Earnings Per Share | (2.45) X | ||||
| Market Capitalization | 2.7 B | ||||
| Total Asset | 4.38 B | ||||
| Retained Earnings | 807.85 M | ||||
| Working Capital | 739.43 M | ||||
| Current Asset | 505.01 M | ||||
| Current Liabilities | 42.62 M | ||||
About ICU Medical Performance
To evaluate ICU Medical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when ICU Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare ICU Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand ICU Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents ICU's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 167.15 | 175.51 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Things to note about ICU Medical performance evaluation
Checking the ongoing alerts about ICU Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ICU Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 2.26 B. Net Loss for the year was (29.66 M) with profit before overhead, payroll, taxes, and interest of 697.76 M. | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Campbell CO Investment Adviser LLC Cuts Stock Position in ICU Medical, Inc. - MarketBeat |
- Analyzing ICU Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ICU Medical's stock is overvalued or undervalued compared to its peers.
- Examining ICU Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ICU Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ICU Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ICU Medical's stock. These opinions can provide insight into ICU Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets |